arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Revolution Medicines, Inc.

RVMD Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$149.23
▼ -4.2% Today
as of Jun 7, 07:26 ET
Last 30 days +3.04% Apr 28 → Jun 05
$137.54 $144.56 $151.58 $158.60 $165.62 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$153.67
High
$154.97
Low
$148.15
Volume
$2M
Avg Vol
$3M
Mkt Cap
$32.9B
P/E (TTM)
Beta
52w High
$166.50
52w Low
$34.00
Div Yield
Shares Out
$200M

Overview

52-week range
$34
$166
87% of range
Avg surprise (last 2)
-13.0%
Avg reaction (last 2)
+1.6%
100% positive
Latest IV / EM
50%
EM ±6.9% · $150 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-2.29$-1.89$-1.50$-1.10$-0.70 Actual $-0.92Actual $-0.99Actual $-0.70Actual $-0.81Actual $-0.94Actual $-1.13Est $-1.12Actual $-1.31Actual $-1.61Actual $-2.29Est $-1.83 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-454M$-375M$-297M$-218M$-140M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $-2.29 $-1.83 -25.1% -102.7% +2.6% earnings
Tue Sep 30, 2025Sep 2025 $-1.61 financials
Mon Jun 30, 2025Jun 2025 $-1.31 financials
Wed May 7, 2025Mar/2025 $-1.13 $-1.12 -0.9% +0.6% earnings
Mon Sep 30, 2024Sep 2024 $-0.94 financials
Sun Jun 30, 2024Jun 2024 $-0.81 financials
Sun Mar 31, 2024Mar 2024 $-0.70 financials
Sat Sep 30, 2023Sep 2023 $-0.99 financials
Fri Jun 30, 2023Jun 2023 $-0.92 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$0$0
Cost of revenue
Gross profit
Operating income$-445M$-315M$-265M$-241M$-176M$-157M
Net income$-454M$-305M$-248M$-213M$-156M$-133M
EPS (diluted)$-2.29$-1.61$-1.31$-1.13$-0.94$-0.81

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$441M$384M$217M$402M$334M$543M$201M$276M
Inventory
Total current assets$1.97B$2.08B$1.98B$2.18B$2.13B$2.33B$1.58B$1.62B
Total assets$2.25B$2.35B$2.25B$2.43B$2.37B$2.56B$1.76B$1.81B
Long-term debt
Total liabilities$754M$723M$655M$564M$287M$293M$197M$190M
Total equity$1.50B$1.63B$1.60B$1.87B$2.08B$2.27B$1.57B$1.62B

Implied volatility — last 90 days

44%47%49%52%54% Jun 07 — IV 50% · EM ±6.9%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.